Roche Takeover Ignites FMI Stock Rally
Biotech stocks continued to outperform last week, with one standout in particular catching my eye. I'm talking, of course, about Foundation Medicine Inc (NASDAQ:FMI). You might have noticed its shares jump 29% in a single trading session.
In this report, we'll take a closer look at the FMI stock explosion, what caused it, and what it means for our FMI stock forecast.
The story begins in 2015, when Roche Holding AG (OTCMKTS:RHHBY), a Swiss company that owns multiple properties in the biotech space, bought 56% of FMI's tradable shares.
Roche completed the deal via a $780.0-million tender.
Den vollständigen Artikel lesen ...
Biotech stocks continued to outperform last week, with one standout in particular catching my eye. I'm talking, of course, about Foundation Medicine Inc (NASDAQ:FMI). You might have noticed its shares jump 29% in a single trading session.
In this report, we'll take a closer look at the FMI stock explosion, what caused it, and what it means for our FMI stock forecast.
The story begins in 2015, when Roche Holding AG (OTCMKTS:RHHBY), a Swiss company that owns multiple properties in the biotech space, bought 56% of FMI's tradable shares.
Roche completed the deal via a $780.0-million tender.
Den vollständigen Artikel lesen ...